Ion Beam Applications SA (IBAB)
Euronext
Closed
Aug 25, 2026
Day's Range
15.7652 wk Range
9.90Overview - IBAB - Ion Beam Applications SA
Key Statistics
Valuation
Enterprise Value
502.92M
P/E (Trailing)
‪37.71‬
P/E (Forward)
‪14.60‬
PEG Ratio
‪14.60‬
Price / Sales (TTM)
‪0.74‬
Price / Book
‪3.65‬
EV / EBITDA
‪12.58‬
Profitability
Profit Margin
‪2.05%‬
Operating Margin
‪8.79%‬
Return on Assets
‪3.32%‬
Return on Equity
‪10.69%‬
Ownership
Shares Outstanding
29.38M
Float
19.44M
Held by Insiders
‪36.09%‬
Held by Institutions
‪24.09%‬
Price stats
Beta
‪1.21‬
50-Day Avg
‪16.39‬
200-Day Avg
‪14.50‬
Dividends
Payout Ratio
‪57.10%‬
Analyst Consensus
4 analysts
Market Cap - IBAB - Ion Beam Applications SA
Peers - IBAB - Ion Beam Applications SA
Peer Comparison
Compared with companies in Medical Devices listed on Euronext.
- IBABEuronextIon Beam Applications SA459.99MMarket Cap+22.73%52-week change37.71P/E (Trailing)‪2.05%‬Profit Margin
- PHIAEuronextKoninklijke Philips N.V.23.07BMarket Cap-1.06%52-week change20.71P/E (Trailing)‪6.30%‬Profit Margin
- IDLEuronextID Logistics Group SA2.20BMarket Cap-18.07%52-week change38.04P/E (Trailing)‪1.69%‬Profit Margin
- NANOEuronextNanobiotix S.A.1.73BMarket Cap+78.44%52-week change—P/E (Trailing)‪-73.51%‬Profit Margin
- CVXEuronextCarvolix SA380.87MMarket Cap+74.93%52-week change-19.35P/E (Trailing)‪20.78%‬Profit Margin
- CVCVEuronextZCI Limited317.47MMarket Cap+45.05%52-week change—P/E (Trailing)‪-186.77%‬Profit Margin
- AFMEEuronextAffluent Medical S.A.240.50MMarket Cap+76.80%52-week change-19.24P/E (Trailing)‪-279.96%‬Profit Margin
Profile Summary - IBAB - Ion Beam Applications SA
About
Ion Beam Applications SA is a global leader in particle accelerator technology, specializing in the design, production, and marketing of innovative solutions for cancer diagnosis and treatment. Operating primarily through its Proton Therapy and Other Accelerators segment, the company develops medical and industrial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
